Furthermore, the effect of ROI information was investigated and the results indicated that using tumor ROI did not improve prediction accuracies for IDH and MGMT mutations in GBM patients (Supplementary Figures S1 and S2). The gene discussed is IDH2; the disease is glioblastoma.